MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. In a recent publication, Severens et al. analyzed Europe-wide perspectives on the implementation of the EU HTA Regulation, mapping key implementation challenges and proposing actions to support a smoother transition.

In November 2025, the HTA body of Tuscany Regional Healthcare published six rapid HTA reports (five new assessments and one reassessment) on medical devices in the cardiovascular, gastroenterology, ophthalmology, dermatology and surgical fields.

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better. From the week of December 1st, we plan to work on 23 projects. Review the complete list of planned activities in this post.

In November 2025, the National Institute for Health and Care Excellence (NICE) published one new Interventional Procedures Guidance on low-energy contact X-ray brachytherapy for rectal cancer with different recommendations depending on clinical indications. Furthermore, three new clinical guidelines were released.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, De Cassai et al. presented a comprehensive methodological guide outlining how to design, conduct, and report high-quality systematic reviews across biological and health sciences.

The French National Authority for Health (HAS) released new recommendations on the registration of medical devices and medical aids in the List of Reimbursable Products and Services (LPPR) following the November 2025 meetings of the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS). One favourable opinion was issued concerning add-on reimbursement for medical device in the gastrointestinal field.

On November 17, 2025, the UK National Screening Committee (UK NSC) launched a consultation on the 2025 evidence map relating to population screening for bladder cancer, which is not currently recommended in the UK. The evidence review found no substantial new evidence to change existing recommendations or commissioning further evidence synthesis work. The topic should be reconsidered by the UK NSC in three years. Organizations and the public are invited to submit comments until February 9, 2026.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. In a recent publication, Mezei et al. examined regulatory and methodological barriers affecting digital health technologies, drawing on surveys, interviews, and focus groups with developers from ten European countries.

On November 7, 2025, the Health Reform Partnership held a meeting, comprising representatives from the federal states, the social insurance system, the Association of Cities and Municipalities, and the governing parties. It was agreed that the federal government and the states are jointly assuming responsibility for a comprehensive reform agenda.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Choi et al. explored the concept of heterogeneity in meta-analyses, aiming to review the main sources of heterogeneity between studies and how it shapes pooled estimates.

On November 13, 2025, the National Association of Statutory Health Insurance Physicians (KBV) announced that the 2026 Hybrid DRGs catalog had been approved. A total of 47 new Hybrid DRGs were added, including those for appendectomy, cholecystectomy, as well as minimally invasive procedures on the coronary arteries and peripheral vessels. In the area of orthopedic procedures, Hybrid DRGs have been expanded to include fracture osteosynthesis

In late October 2025, the Decision Forum for the "New Methods" framework made a favorable coverage decision for magnetic resonance-guided high-intensity focused ultrasound (MRgFUS, ExAblate Neuro by Insightec) for the treatment of essential tremor.